Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7072 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H19-09 |
filingDate |
2004-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2006-12-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2006528989-A |
titleOfInvention |
Treatment of pancreatic cancer |
abstract |
The N 4 derivatives of the known antitumor compound CNDAC are useful in the treatment of pancreatic cancer, particularly as an adjunct therapy, and more particularly for long-term administration. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2010527908-A |
priorityDate |
2003-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |